US HB8905 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on December 8 2020 - 25% progression, died in committee
Action: 2020-12-08 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 8 2020 - 25% progression, died in committee
Action: 2020-12-08 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to reduce the threat of counterfeit drugs to the pharmaceutical supply chain, and to make the pharmaceutical supply chain more robust, while ensuring the authenticity, content, purity, and manufacturing location and batch number of drugs (including COVID-19 therapeutics and vaccines) and allowing patient verification of authenticity, and for other purposes.
Title
Supply Chain Security and Pharmaceutical Authentication Act of 2020
Sponsors
| Rep. Jeff Van Drew [R-NJ] |
History
| Date | Chamber | Action |
|---|---|---|
| 2020-12-08 | House | Referred to the House Committee on Energy and Commerce. |
| 2020-12-08 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/8905/all-info |
| Text | https://www.congress.gov/116/bills/hr8905/BILLS-116hr8905ih.pdf |
